TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Lee’s Pharmaceutical Holdings Limited ( (HK:0950) ) is now available.
Lee’s Pharmaceutical Holdings Limited announced a substantial financial performance improvement for the year ended December 31, 2024. The company reported a 32.9% increase in revenue and a 457.5% rise in profit attributable to owners compared to the previous year. This significant growth is reflected in the earnings per share, which also saw a dramatic increase. The Board has recommended a final dividend of HK2.5 cents per share, highlighting confidence in the company’s financial health and future prospects.
More about Lee’s Pharmaceutical Holdings Limited
Lee’s Pharmaceutical Holdings Limited is a company incorporated in the Cayman Islands, operating primarily in the pharmaceutical industry. It focuses on developing, manufacturing, and marketing pharmaceutical products, with a significant emphasis on the Asian market.
Average Trading Volume: 285,012
Technical Sentiment Signal: Sell
Current Market Cap: HK$836.1M
For an in-depth examination of 0950 stock, go to TipRanks’ Stock Analysis page.